相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells
Sara Trabanelli et al.
JOURNAL OF IMMUNOLOGY (2014)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
H. Yang et al.
LEUKEMIA (2014)
Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients
G. Visani et al.
LEUKEMIA (2014)
Mesenchymal Stromal Cells Derived from the Bone Marrow of Acute Lymphoblastic Leukemia Patients Show Altered BMP4 Production: Correlations with the Course of Disease
Angeles Vicente Lopez et al.
PLOS ONE (2014)
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
Francis Mussai et al.
BLOOD (2013)
RNA Trafficking by Acute Myelogenous Leukemia Exosomes
Jianya Huan et al.
CANCER RESEARCH (2013)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Liza B. John et al.
CLINICAL CANCER RESEARCH (2013)
Forced expression of indoleamine-2,3-dioxygenase in human umbilical cord-derived mesenchymal stem cells abolishes their anti-apoptotic effect on leukemia cell lines in vitro
Yin Yuan et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2013)
Harnessing the Immune System for the Treatment of Non-Small-Cell Lung Cancer
Julie R. Brahmer
JOURNAL OF CLINICAL ONCOLOGY (2013)
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
Li Shi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML
G. Ramsingh et al.
LEUKEMIA (2013)
Physiological Roles and Potential Therapeutic Applications of the P2X7 Receptor in Inflammation and Pain
Luiz Anastacio Alves et al.
MOLECULES (2013)
Biological, Functional and Genetic Characterization of Bone Marrow-Derived Mesenchymal Stromal Cells from Pediatric Patients Affected by Acute Lymphoblastic Leukemia
Antonella Conforti et al.
PLOS ONE (2013)
Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients
Alessandro Isidori et al.
EXPERT REVIEW OF HEMATOLOGY (2013)
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice
Valentina Salvestrini et al.
BLOOD (2012)
Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
Michael Platten et al.
CANCER RESEARCH (2012)
Purines, Purinergic Receptors, and Cancer
Francesco Di Virgilio
CANCER RESEARCH (2012)
CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
Peter A. Prieto et al.
CLINICAL CANCER RESEARCH (2012)
Extracellular ATP Exerts Opposite Effects on Activated and Regulatory CD4+ T Cells via Purinergic P2 Receptor Activation
Sara Trabanelli et al.
JOURNAL OF IMMUNOLOGY (2012)
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
D. A. Pollyea et al.
LEUKEMIA (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
Todd A. Fehniger et al.
BLOOD (2011)
Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts
Olga Blau et al.
BLOOD (2011)
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells
Armel Herve Nwabo Kamdje et al.
BLOOD (2011)
Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?
Celalettin Ustun et al.
BLOOD (2011)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
Jitka Fucikova et al.
CANCER RESEARCH (2011)
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Jessica Godin-Ethier et al.
CLINICAL CANCER RESEARCH (2011)
Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)
Juliana Croitoru-Lamoury et al.
PLOS ONE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'
Tae Hoon Lee et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Pawel Bodera et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2011)
Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias
Jing-Hui Chong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Lenalidomide mode of action: linking bench and clinical findings
Faith Davies et al.
BLOOD REVIEWS (2010)
Integration of Host-Related Signatures with Cancer Cell-Derived Predictors for the Optimal Management of Anticancer Chemotherapy
Laurence Zitvogel et al.
CANCER RESEARCH (2010)
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells
Antonio Curti et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias
William Blum et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma
Shari Pilon-Thomas et al.
JOURNAL OF IMMUNOLOGY (2010)
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Marc H. G. P. Raaijmakers et al.
NATURE (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
M. Wemeau et al.
CELL DEATH & DISEASE (2010)
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
Zhihong Zeng et al.
BLOOD (2009)
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)
Ivan M. Borrello et al.
BLOOD (2009)
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
Rifca Le Dieu et al.
BLOOD (2009)
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
Long Zhang et al.
BLOOD (2009)
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
Stefan Loeb et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Exosomes - vesicular carriers for intercellular communication
Mikael Simons et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug
Alan G. Ramsay et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Mechanism of action of lenalidomide in hematological malignancies
Venumadhav Kotla et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy
A. Perez-Garcia et al.
LEUKEMIA (2009)
Contribution of bone microenvironment to leukemogenesis and leukemia progression
F. Ayala et al.
LEUKEMIA (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
P2X7: a growth-promoting receptor-implications for cancer
Francesco Di Virgilio et al.
PURINERGIC SIGNALLING (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
How do mesenchymal stromal cells suppress T cells?
Armand Keating
CELL STEM CELL (2008)
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
Raanan Berger et al.
CLINICAL CANCER RESEARCH (2008)
High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
M. E.D. Chamuleau et al.
HAEMATOLOGICA (2008)
Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells
J. M. Ryan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease
S. Fevery et al.
LEUKEMIA (2007)
Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia
Olga Blau et al.
EXPERIMENTAL HEMATOLOGY (2007)
Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma
B. Arnulf et al.
LEUKEMIA (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion
Saengsuree Jootar et al.
LEUKEMIA RESEARCH (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Immunoregulatory function of mesenchymal stem cells
Antonio Uccelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Mesenchymal stem cells in myelodysplastic syndromes:: phenotypic and cytogenetic characterization
E Flores-Figueroa et al.
LEUKEMIA RESEARCH (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
IDO and tolerance to tumors
DH Munn et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Identification of the haematopoietic stem cell niche and control of the niche size
JW Zhang et al.
NATURE (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors
E Adinolfi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Immunotherapy of established tumors using bone marrow transplantation with antigen gene-modified hematopoietic stem cells
Y Cui et al.
NATURE MEDICINE (2003)
Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms
Y Nefedova et al.
LEUKEMIA (2003)
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide
M Krampera et al.
BLOOD (2003)
Tolerance, DCs and tryptophan: much ado about IDO
U Grohmann et al.
TRENDS IN IMMUNOLOGY (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
SS Farag et al.
BLOOD (2002)
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins
M Konopleva et al.
LEUKEMIA (2002)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function - implications for the adoptive immunotherapy of leukaemia
JK Orleans-Lindsay et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-κB, c-myc, and pRb pathways
AGS Buggins et al.
JOURNAL OF IMMUNOLOGY (2001)
Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells
BK Cho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
